In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 |
| 10-K | 10-K | 10-K | 10-K | S-1 |
Revenues: |
Supplements | | | 0.2 | | |
Total revenues [+] | 0.5 | 0.7 | 0.0 | 19.0 | |
Royalties | | | 0.0 | | |
Revenue growth | -34.6% | 2310.0% | -99.8% | | |
Cost of goods sold | 0.0 | 0.3 | 0.0 | 0.0 | |
Gross profit | 0.4 | 0.4 | 0.0 | 19.0 | |
Gross margin | 94.5% | 60.0% | 100.0% | 100.0% | |
Selling, general and administrative [+] | 16.9 | 22.0 | 20.4 | 9.5 | |
Sales and marketing | | | | 2.7 | |
General and administrative | 16.9 | 22.0 | | 6.8 | |
Other selling, general and administrative | | | | 2.7 | |
Research and development | 31.9 | 28.4 | | 9.6 | |
Other operating expenses | | | -18.8 | 16.3 | |
EBITDA [+] | -47.4 | -49.0 | | -15.5 | |
EBITDA growth | -3.3% | 3022.5% | -89.9% | | |
EBITDA margin | -10019.0% | -6780.5% | -5233.3% | -81.3% | |
Depreciation and amortization | 1.0 | 1.0 | | 0.8 | |
EBIT [+] | -48.4 | -50.0 | -1.6 | -16.3 | |
EBIT growth | -3.1% | 3083.3% | -90.4% | | |
EBIT margin | -10234.5% | -6912.6% | -5233.3% | -85.8% | |
Interest expense | 3.3 | 0.9 | | 0.1 | |
Interest expense | 3.3 | 0.9 | 1.0 | 0.1 | |
Other income (expense), net [+] | 21.8 | 40.7 | -16.4 | 0.3 | |
Gain (loss) on debt retirement | 0.4 | | | | |
Unrealized gain/loss on derivatives | 0.2 | 1.0 | 14.6 | | |
Other | 0.3 | 0.0 | | 0.0 | |
Pre-tax income | -29.9 | -10.2 | -18.9 | -16.2 | |
Income taxes | 0.0 | -0.4 | 0.4 | 0.0 | |
Tax rate | 0.0% | 4.2% | | 0.0% | |
Net income | -29.9 | -9.7 | -19.3 | -16.2 | |
Net margin | -6325.2% | -1347.2% | -64256.7% | -84.9% | |
|
Basic EPS [+] | ($0.46) | ($0.16) | ($1.10) | ($0.93) | |
Growth | 190.0% | -85.6% | 18.3% | | |
Diluted EPS [+] | ($0.46) | ($0.16) | ($1.10) | ($0.93) | |
Growth | 190.0% | -85.6% | 18.3% | | |
|
Shares outstanding (basic) [+] | 65.2 | 61.6 | 17.5 | 17.4 | |
Growth | 5.9% | 251.7% | 0.8% | | |
Shares outstanding (diluted) [+] | 65.2 | 61.6 | 17.5 | 17.4 | |
Growth | 5.9% | 251.7% | 0.8% | | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |